CID 15954162

N-[2-(5-morpholino-1,3,4-oxadiazol-2-yl)ethoxy]-1-phenyl-ethanimine

Structural Information

Molecular Formula
C16H20N4O3
SMILES
C/C(=N\OCCC1=NN=C(O1)N2CCOCC2)/C3=CC=CC=C3
InChI
InChI=1S/C16H20N4O3/c1-13(14-5-3-2-4-6-14)19-22-10-7-15-17-18-16(23-15)20-8-11-21-12-9-20/h2-6H,7-12H2,1H3/b19-13+
InChIKey
FYRGSYBVMHBOGQ-CPNJWEJPSA-N
Compound name
(E)-N-[2-(5-morpholin-4-yl-1,3,4-oxadiazol-2-yl)ethoxy]-1-phenylethanimine
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

316.15353 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 317.16081 173.9
[M+Na]+ 339.14275 178.2
[M-H]- 315.14625 181.1
[M+NH4]+ 334.18735 182.5
[M+K]+ 355.11669 177.6
[M+H-H2O]+ 299.15079 162.4
[M+HCOO]- 361.15173 191.7
[M+CH3COO]- 375.16738 183.5
[M+Na-2H]- 337.12820 177.4
[M]+ 316.15298 174.4
[M]- 316.15408 174.4
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.